A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis

NCT07684157 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG: JAB-8263
DRUG: JAB-8263

Sponsor

Jacobio Pharmaceuticals Co., Ltd.